Skip To Main Content
Rom Leidner on Muck Rack

Rom Leidner

As seen in: The BMJ, BioRxiv, OncLive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rom

Contact Rom, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

|
By Robert Ferris Verified, Rom Leidner, Antonio Jimeno
| The BMJ Verified
Contributors: Study design: EEWC, RSL. Study investigator: JEG-O, CHC, RLF, RR, SML, EEWC, RSL, AS. Enrolled patients: JEG-O, CHC, RLF, EEWC, RR, SML, RSL, AS. Collection and assembly of data: MY, RLF, RF, MC, EEWC, RSL. Data analysis: MY, RLF, EEWC. Data interpretation: RLF, RSL, CHC, AJ, SML, AS, JJN, JEG-O, RR, SJW, VMV, JM, FGF, JC, BG, RF, MC, MY, EEWC. Manuscript preparation: EEWC.
Open in Who Shared Issue with article?

1481 Off-the-shelf dark matter immunotherapy in head & neck cancer: mechanistic insights and clinical efficacy

|
By Rom Leidner, Shawn Jensen, Christopher Paustian, Tarsem Moudgil
| The BMJ Verified
Abstract Background DPV-001 is an off-the-shelf biologic containing proteins that are overexpressed by adenocarcinoma and squamous cell cancers.
Open in Who Shared Issue with article?

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

|
By David A. Knorr, Rom Leidner, Shawn Jensen, Ryan Meng
| BioRxiv
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (697) Issue with article?
See all 4 licensed articles (7 Total)